Key result
Warfarin therapy can lead to diffuse alveolar hemorrhage, presenting as a rare and life-threatening complication.
Warfarin therapy can be associated with diffuse alveolar hemorrhage, highlighting a rare but life-threatening bleeding complication.
Warfarin may rarely cause diffuse alveolar hemorrhage; this case extends the known spectrum but leaves open systematic risk assessment.
Diffuse alveolar hemorrhage (DAH) is a life-threatening clinical pathologic syndrome caused by a variety of diseases. We report a case of DAH related to therapy of warfarin use. In this case report, we present the diffuse alveolar hemorrhage case as a rare and life-threatening complication of warfarin.
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2015) studied this question. Warfarin therapy can lead to diffuse alveolar hemorrhage, presenting as a rare and life-threatening complication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: